Mechanisms of Fungal Resistance: An Overview

Balkis, M.M.; Leidich, S.D.; Mukherjee, P.K.; Ghannoum, M.A.
April 2002
Drugs;2002, Vol. 62 Issue 7, p1025
Academic Journal
The increased use of antifungal agents in recent years has resulted in the development of resistance to these drugs. The significant clinical implication of resistance has led to heightened interest in the study of antifungal resistance from different angles. In this article we discuss antifungal susceptibility testing, the mode of action of antifungals and mechanisms of resistance. Antifungals are grouped into five groups on the basis of their site of action: azoles, which inhibit the synthesis of ergosterol (the main fungal sterol); polyenes, which bind to fungal membrane sterol, resulting in the formation of aqueous pores through which essential cytoplasmic materials leak out; allylamines, which block ergosterol biosynthesis, leading to accumulation of squalene (which is toxic to the cells); candins (inhibitors of the fungal cell wall), which function by inhibiting the synthesis of β 1,3-glucan (the major structural polymer of the cell wall); and flucytosine, which inhibits macromolecular synthesis. Different mechanisms contribute to the resistance of antifungal agents. These mechanisms include modification of ERG11 gene at the molecular level (gene mutation, conversion and overexpression), over expression of specific drug efflux pumps, alteration in sterol biosynthesis, and reduction in the intracellular concentration of target enzymes. Approaches to prevent and control the emergence of antifungal resistance include prudent use of antifungals, treatment with the appropriate antifungal and conducting surveillance studies to determine the frequency of resistance.


Related Articles

  • Antifungal Drug Resistance. Loeffler, Juergen; Stevens, David A. // Clinical Infectious Diseases;1/15/2003 Supplement 1, Vol. 36, pS31 

    The increasing incidence of invasive fungal infections is the result of many factors, including an increasing number of patients with severe immunosuppression. Although new drugs have been introduced to combat this problem, the development of resistance to antifungal drugs has become...

  • Fatal fungal infections resist newest class of drugs.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p161 

    The article reports on the resistance of severe fungal infections among patients with compromised immune systems on antifungal drugs which was being discussed at the Society for General Microbiology's Autumn Conference in 2011.

  • Resistance amongst yeasts isolated from the oral cavities of patients with advanced cancer. Davies, Andrew; Brailsford, Susan; Broadley, Karen; Beighton, David // Palliative Medicine;Oct2002, Vol. 16 Issue 6, p527 

    The aim of this study was to determine the prevalence of in vitro resistance amongst yeasts isolated from the oral cavities of patients with advanced cancer. The National Committee for Clinical Laboratory Standards' broth microdilution method was used to determine the sensitivities to...

  • Editorial Commentary: Voriconazole Resistance in Aspergillus fumigatus: Should We Be Concerned? Denning, David W.; Bowyer, Paul // Clinical Infectious Diseases;Aug2013, Vol. 57 Issue 4, p521 

    An introduction is presented in which the editor discusses a report within the issue on topics including voriconazole resistance, allergic bronchopulmonary aspergillosis and antifungal therapy.

  • Nuances of new anti- Aspergillus antifungals. Perfect, J. R. // Medical Mycology;Feb2005 Supplement 1, Vol. 43, p271 

    Invasive aspergillosis (IA) is a serious complication of immunosuppression, and has become more widespread as the immunocompromised population has increased as a result of new treatment strategies and diseases. This paper identifies and discusses seven issues for managing IA and combating drug...

  • A novel polyamide SL-A92 as a potential fungal resistance blocker: synthesis and bioactivities in Candida albicans. Shao-long ZHU; Zhi-hui JIANG; Ping-hui GAO; Yue QIU; Liang WANG; Yuan-ying JIANG; Da-zhi ZHANG // Acta Pharmacologica Sinica;Jul2010, Vol. 31 Issue 7, p855 

    AbstractAim:To synthesize a novel polyamide SL-A92 and evaluate its bioactivity against drug resistance in Candida albicans.Methods:SL-A92 was synthesized using N-hydroxybenzotriazole (HOBT)/N,N'-dicyclohexylcarbodiimide (DCC) in solution phase. Its antifungal activities and effects on strain...

  • Currently Used Antimycotics: Spectrum, Mode of Action and Resistance Occurrence. Fran�ois, Isabelle E. J. A.; Aerts, An M.; Cammue, Bruno P. A.; Thevissen, Karin // Current Drug Targets;Dec2005, Vol. 6 Issue 8, p895 

    The increasing incidence of fungal infections combined with the emerging problem of antifungal drug resistance have prompted investigations of the mode of action of the currently used antifungal therapeutics (antimycotics). The routinely used antimycotics can be grouped into six different...

  • In-vitro susceptibility of Aspergillus species isolated from cutaneous and visceral lesions to antifungal agents. Hashemi, Jamal; Zaini, Farideh; Daie, Roshanak; Zibafar, Ensie; Zakeri, Mir Abolfazl // Tehran University Medical Journal;May2011, Vol. 69 Issue 2, p83 

    Background: Different studies have shown that despite the expanding number of antifungal agents, death rate caused by Aspergillus species has been increased during the recent decades due to drug-resistance occurrence, increased minimum inhibitory concentration (MIC) and cross-resistance among...

  • Antifungal Resistance Mechanisms of Aspergillus. Jianjun Qiao; Wei Liu; Ruoyu Li // Japanese Journal of Medical Mycology;Sep2008, Vol. 49 Issue 3, p157 

    The incidence of invasive aspergillosis (IA), which is commonly caused by Aspergillus fumigatus, has increased recently in immunicompromised patients and has become the common cause of death in these patients. Antifungal resistance is one of the reasons for treatment failure. Since the first...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics